4
Changes in Ownership
Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-005130
Chief Business Officer sold 4,849 shares at $12.01 ($58,236)
- Chief Business Officer acquired 8,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Martin Michael Robert · Chief Business Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-02 | Grant or award : show line 1 in the form | +8,500 | 64,361 | D | ||
| 2022-03-02 | Sale : show line 2 in the form | −4,849 | $12.01 | $58,236 | 59,512 | D |
| Open-market sales · 4,849 sh · avg $12.01 · $58,236 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-02 | Grant or award : show line 3 in the form Restricted Stock Unit | +62,448 | 62,448 | D |
| 2022-03-02 | Grant or award : show line 4 in the form Stock Option (right to buy) | +106,838 | 106,838 | D |
Loading xslF345X03/wf-form4_164642837303389.xml…